Sosei Heptares to host R&D Day highlighting its innovative R&D and translational medicine approaches to drug discovery and strong pipeline momentum

Tokyo, Japan and Cambridge, UK, 27 September 2022 – Sosei Group Corporation (“the Company”; TSE: 4565) will hold an R&D Day on Thursday, 13 October 2022, at 3:30 pm JST. The meeting will be held in person in Tokyo for institutional investors, securities analysts and the press and will also be available via a live webcast. Please click here to register for the event.

Date: Thursday, 13 October 2022

Time: 3:30 pm – 5:30 pm JST (7:30 am – 9:30 am BST)

Presenters:   Chris Cargill, President and CEO     

Corporate presentation, vision, strategy and progress

Matt Barnes, Head of UK R&D

Focusing on out-licensed and partnered programs

Rie Suzuki, Senior Director, Translational Biology

Focused on wholly owned, in-house programs